{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:22:33Z","timestamp":1707524553330},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,26]]},"DOI":"10.7759\/cureus.21629","type":"journal-article","created":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T14:35:31Z","timestamp":1643207731000},"source":"Crossref","is-referenced-by-count":1,"title":["Resource-Limited Management of Presumptive Pyoderma Gangrenosum in an Unsheltered Patient"],"prefix":"10.7759","author":[{"given":"Taha F","family":"Rasul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jackson D","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel R","family":"Bergholz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armen","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.19051","article-title":"Homeless status and associations with treatment disparities for common skin conditions","volume":"183","author":"Truong A","year":"2020","unstructured":"Truong A, Secrest AM, Fino NF, Laggis CW, Lewis BK. Homeless status and associations with treatment disparities for common skin conditions. Br J Dermatol. 2020, 183:582-4. 10.1111\/bjd.19051","journal-title":"Br J Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2019.1606888","article-title":"Clinical factors influencing the response to intravenous immunoglobulin treatment in cases of treatment-resistant pyoderma gangrenosum","volume":"31","author":"Haag CK","year":"2020","unstructured":"Haag CK, Ortega-Loayza AG, Latour E, Keller JJ, Fett NM. Clinical factors influencing the response to intravenous immunoglobulin treatment in cases of treatment-resistant pyoderma gangrenosum. J Dermatolog Treat. 2020, 31:723-6. 10.1080\/09546634.2019.1606888","journal-title":"J Dermatolog Treat"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.17122","article-title":"Assessing the severity of pyoderma gangrenosum: a need for validated measurement tools","volume":"180","author":"Dorrell DN","year":"2019","unstructured":"Dorrell DN, Huang WW. Assessing the severity of pyoderma gangrenosum: a need for validated measurement tools. Br J Dermatol. 2019, 180:217-8. 10.1111\/bjd.17122","journal-title":"Br J Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.16789","article-title":"Could we be doing more to provide an evidence base for rare skin conditions?","volume":"179","author":"Thomas KS","year":"2018","unstructured":"Thomas KS. Could we be doing more to provide an evidence base for rare skin conditions?. Br J Dermatol. 2018, 179:240-1. 10.1111\/bjd.16789","journal-title":"Br J Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/iwj.13359","article-title":"Successful treatment of a refractory pyoderma gangrenosum with risankizumab","volume":"17","author":"Burgdorf B","year":"2020","unstructured":"Burgdorf B, Schlott S, Ivanov IH, Dissemond J. Successful treatment of a refractory pyoderma gangrenosum with risankizumab. Int Wound J. 2020, 17:1086-8. 10.1111\/iwj.13359","journal-title":"Int Wound J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2018.07.016","article-title":"Two cases of maggot debridement therapy in pyoderma gangrenosum","volume":"4","author":"Din RS","year":"2018","unstructured":"Din RS, Tsiaras WG, Mostaghimi A. Two cases of maggot debridement therapy in pyoderma gangrenosum. JAAD Case Rep. 2018, 4:1027-9. 10.1016\/j.jdcr.2018.07.016","journal-title":"JAAD Case Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.31146\/1682-8658-ecg-175-3-113-117","article-title":"[Skin manifestations of inflammatory bowel diseases]","volume":"3","author":"Kudishina MM","year":"2020","unstructured":"Kudishina MM, Kozlova IV, Yavaeva EA. [Skin manifestations of inflammatory bowel diseases]. Eksp Klin Gastroenterol. 2020, 3:113-7. 10.31146\/1682-8658-ecg-175-3-113-117","journal-title":"Eksp Klin Gastroenterol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.19909.1","article-title":"Recent advances in managing and understanding pyoderma gangrenosum","volume":"8","author":"Fletcher J","year":"2019","unstructured":"Fletcher J, Alhusayen R, Alavi A. Recent advances in managing and understanding pyoderma gangrenosum. F1000Res. 2019, 8:F1000 Faculty Rev-2092. 10.12688\/f1000research.19909.1","journal-title":"F1000Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8819560","article-title":"Cutaneous coinfection of cytomegalovirus and Mycobacterium chelonae accelerated by immunosuppression","volume":"2021","author":"Tsutsumi Y","year":"2021","unstructured":"Tsutsumi Y, Odani K, Kaneko Y, Hashizume H, Tachibana M. Cutaneous coinfection of cytomegalovirus and Mycobacterium chelonae accelerated by immunosuppression. Case Rep Pathol. 2021, 2021:8819560. 10.1155\/2021\/8819560","journal-title":"Case Rep Pathol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpm.2021.06.002","article-title":"Pyoderma gangrenosum: a literature review","volume":"38","author":"Barbe M","year":"2021","unstructured":"Barbe M, Batra A, Golding S, Hammond O, Higgins JC, O'Connor A, Vlahovic TC. Pyoderma gangrenosum: a literature review. Clin Podiatr Med Surg. 2021, 38:577-88. 10.1016\/j.cpm.2021.06.002","journal-title":"Clin Podiatr Med Surg"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.20474","article-title":"Comorbidities, mortality and survival in patients with pyoderma gangrenosum: a Danish nationwide registry-nested case-control study","volume":"185","author":"Ben Abdallah H","year":"2021","unstructured":"Ben Abdallah H, Bech R, Fogh K, Olesen AB, Vestergaard C. Comorbidities, mortality and survival in patients with pyoderma gangrenosum: a Danish nationwide registry-nested case-control study. Br J Dermatol. 2021, 185:1169-75. 10.1111\/bjd.20474","journal-title":"Br J Dermatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.5811\/cpcem.2021.3.51733","article-title":"Young woman with leg lesions","volume":"5","author":"Finnin D","year":"2021","unstructured":"Finnin D. Young woman with leg lesions. Clin Pract Cases Emerg Med. 2021, 5:265-6. 10.5811\/cpcem.2021.3.51733","journal-title":"Clin Pract Cases Emerg Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.19027","article-title":"Identification and evaluation of outcome measurement instruments in pyoderma gangrenosum: a systematic review","volume":"183","author":"Lu JD","year":"2020","unstructured":"Lu JD, Hobbs MM, Huang WW, Ortega-Loayza AG, Alavi A. Identification and evaluation of outcome measurement instruments in pyoderma gangrenosum: a systematic review. Br J Dermatol. 2020, 183:821-8. 10.1111\/bjd.19027","journal-title":"Br J Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13670","article-title":"The Treg\/Th17 cell ratio is reduced in the skin lesions of patients with pyoderma gangrenosum","volume":"173","author":"Caproni M","year":"2015","unstructured":"Caproni M, Antiga E, Volpi W, et al.. The Treg\/Th17 cell ratio is reduced in the skin lesions of patients with pyoderma gangrenosum. Br J Dermatol. 2015, 173:275-8. 10.1111\/bjd.13670","journal-title":"Br J Dermatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.06.054","article-title":"Postoperative pyoderma gangrenosum (PG): the Mayo Clinic experience of 20 years from 1994 through 2014","volume":"73","author":"Tolkachjov SN","year":"2015","unstructured":"Tolkachjov SN, Fahy AS, Wetter DA, et al.. Postoperative pyoderma gangrenosum (PG): the Mayo Clinic experience of 20 years from 1994 through 2014. J Am Acad Dermatol. 2015, 73:615-22. 10.1016\/j.jaad.2015.06.054","journal-title":"J Am Acad Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/84370-resource-limited-management-of-presumptive-pyoderma-gangrenosum-in-an-unsheltered-patient","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:36:48Z","timestamp":1707507408000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/84370-resource-limited-management-of-presumptive-pyoderma-gangrenosum-in-an-unsheltered-patient"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,26]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.21629","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1,26]]}}}